Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2008

Conditions
Vascular DiseaseCritical Lower Limb Ischemia
Interventions
DRUG

Hemospan (MP4OX)

250 mL of Hemospan (MP4OX)

DRUG

Voluven (HES 130/0.4)

250 mL of Voluven (HES 130/0.4) solution

Trial Locations (1)

Unknown

Karolinska Universitetssjukhuset, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sangart

INDUSTRY